GoHealth Plunges on Q1 Loss Forecast: Analysts Project $1.89/Share Loss, 84% Revenue Drop
GOCO is trading near its 52-week low of $0.97 (0.0% above the low) on light trading volume (0.4× avg).
Summary
GoHealth, Inc. is expected to report a significant loss of $1.89 per share for the first quarter ending March 31, 2026, according to analyst consensus. This forecast also includes a drastic 84.2% year-over-year revenue decline to $35 million. These projections reinforce the severe financial distress highlighted in the company's recent 10-K, which reported a massive net loss for 2025, a going concern warning, and confirmed Nasdaq delisting. The anticipated loss per share is nearly double the company's current stock price, which is trading near its 52-week low. This outlook suggests continued operational challenges and further pressure on the stock, requiring immediate attention from traders. Investors will be closely watching the actual results on May 11 for confirmation of these dire expectations and any commentary on the company's future viability.
At the time of this announcement, GOCO was trading at $0.97 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $28M. The 52-week trading range was $0.97 to $8.75. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.